AgNP-PVP-meglumine antimoniate nanocomposite reduces Leishmania amazonensis infection in macrophages

BACKGROUND: Leishmaniasis is an infectious disease caused by parasites of the genus Leishmania and presents different clinical manifestations. The adverse effects, immunosuppression and resistant strains associated with this disease necessitate the development of new drugs. Nanoparticles have shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Gélvez, Ana Patricia Cacua, Diniz Junior, José Antonio Picanço, Brígida, Rebecca Thereza Silva Santa, Rodrigues, Ana Paula Drummond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276411/
https://www.ncbi.nlm.nih.gov/pubmed/34253188
http://dx.doi.org/10.1186/s12866-021-02267-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276411/
https://www.ncbi.nlm.nih.gov/pubmed/34253188
http://dx.doi.org/10.1186/s12866-021-02267-2

Ejemplares similares